Merrimack Pharmaceuticals Inc (MACK) Insider Trading
- $16,840,297.18
- $13,368,004.02
- Dec. 28, 2023
- Gary L Crocker
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 13, 2015 | Director | 20,000 | $13.00 | Sell | $260,000.00 | |
March 24, 2015 | CEO | 114,368 | $11.71 | Sell | $1,339,249.28 | |
March 23, 2015 | CEO | 10,400 | $11.69 | Sell | $121,576.00 | |
March 20, 2015 | Director | 5,000 | $11.77 | Buy | $58,850.00 | |
March 19, 2015 | Director | 40,000 | $11.97 | Sell | $478,800.00 | |
March 19, 2015 | CFO | 15,000 | $11.97 | Sell | $179,550.00 | |
March 17, 2015 | SVP | 8,000 | $11.95 | Sell | $95,600.00 | |
March 17, 2015 | Director | 1,190 | $11.77 | Buy | $14,006.30 | |
March 17, 2015 | Insider | 42,234 | $12.00 | Sell | $506,808.00 | |
March 16, 2015 | SVP | 6,000 | $11.93 | Sell | $71,580.00 | |
March 16, 2015 | Insider | 20,897 | $12.00 | Sell | $250,764.00 | |
March 11, 2015 | Director | 5,000 | $11.33 | Buy | $56,650.00 | |
March 2, 2015 | Director | 5,000 | $10.93 | Buy | $54,650.00 | |
Feb. 23, 2015 | Director | 20,000 | $10.91 | Sell | $218,200.00 | |
Feb. 20, 2015 | CEO | 150,000 | $10.94 | Sell | $1,641,000.00 | |
Jan. 15, 2015 | SVP | 6,000 | $11.19 | Sell | $67,140.00 | |
Dec. 24, 2014 | CFO | 15,000 | $10.70 | Sell | $160,500.00 | |
Dec. 23, 2014 | Director | 20,000 | $10.23 | Buy | $204,600.00 | |
Dec. 18, 2014 | Director | 20,000 | $10.31 | Sell | $206,200.00 | |
Dec. 15, 2014 | SVP | 6,000 | $10.63 | Sell | $63,780.00 | |
Dec. 8, 2014 | CEO | 200,000 | $9.84 | Sell | $1,968,000.00 | |
Dec. 2, 2014 | Director | 8,000 | $8.71 | Buy | $69,680.00 | |
Nov. 21, 2014 | Director | 11,909 | $8.87 | Buy | $105,632.83 | |
Nov. 18, 2014 | SVP | 5,000 | $8.55 | Sell | $42,750.00 | |
Nov. 14, 2014 | Director | 5,000 | $8.29 | Buy | $41,450.00 | |
Nov. 13, 2014 | Director | 14,390 | $8.47 | Buy | $121,883.30 | |
Nov. 12, 2014 | Director | 40,000 | $8.37 | Buy | $334,800.00 | |
Oct. 23, 2014 | SVP | 3,000 | $9.05 | Sell | $27,150.00 | |
Sept. 30, 2014 | CFO | 105,282 | $8.61 | Sell | $906,478.02 | |
Sept. 29, 2014 | CFO | 64,404 | $8.40 | Sell | $540,993.60 | |
Sept. 24, 2014 | SVP | 12,000 | $8.22 | Sell | $98,640.00 | |
June 23, 2014 | Director | 36,000 | $6.84 | Buy | $246,240.00 | |
May 20, 2014 | Director | 4,000 | $6.69 | Buy | $26,760.00 | |
May 19, 2014 | Director | 9,400 | $6.68 | Buy | $62,792.00 | |
May 16, 2014 | Director | 15,000 | $6.49 | Buy | $97,350.00 | |
May 13, 2014 | Director | 5,000 | $6.74 | Buy | $33,700.00 | |
May 8, 2014 | Director | 10,000 | $6.59 | Buy | $65,900.00 | |
May 7, 2014 | Director | 4,400 | $6.77 | Buy | $29,788.00 | |
May 6, 2014 | Director | 17,500 | $6.89 | Buy | $120,575.00 | |
May 5, 2014 | Director | 15,000 | $6.41 | Buy | $96,150.00 | |
May 5, 2014 | CEO | 5,000 | $6.31 | Buy | $31,550.00 | |
Dec. 17, 2013 | Director | 25,000 | $4.75 | Buy | $118,750.00 | |
Dec. 12, 2013 | SVP | 4,000 | $4.26 | Buy | $17,040.00 | |
Dec. 10, 2013 | Director | 18,000 | $4.38 | Buy | $78,840.00 | |
Dec. 6, 2013 | Director | 39,000 | $4.70 | Buy | $183,300.00 | |
Dec. 4, 2013 | CEO | 33,100 | $4.42 | Buy | $146,302.00 | |
Dec. 3, 2013 | Director | 47,500 | $4.17 | Buy | $198,075.00 | |
Dec. 2, 2013 | SVP | 2,000 | $4.06 | Buy | $8,120.00 | |
Nov. 29, 2013 | Director | 3,800 | $3.92 | Buy | $14,896.00 | |
Nov. 27, 2013 | Director | 207,000 | $3.72 | Buy | $770,040.00 |
Insiders are both buying and selling Merrimack Pharmaceuticals Inc stock.
The insider traders at Merrimack Pharmaceuticals Inc are: Gary L Crocker, Michael E Porter, Noah G Levy, Eric Andersen, Edward J Stewart, Ulrik B Nielsen, William A Sullivan, Edward J. Stewart, Michael Porter, Gary Crocker, Levy Noah G., Robert J Mulroy, Jfl Capital Management, Llc, Birgit M Schoeberl, Jason Aryeh, Vivian S Lee, Lp 22Nw, Anthony Sinskey, Robert Mulroy, William Mcclements, William M Mcclements, Anthony J Sinskey, Daryl C Drummond, Fund Lp 22Nw, Gordon J Fehr, James H Quigley, James Quigley, John Mendelsohn, Sarah Nash, and Ana Radeljevic
The most active insider trader at Merrimack Pharmaceuticals Inc is Gary L Crocker with 25 trades.
Robert J Mulroy has sold the most Merrimack Pharmaceuticals Inc stock with a total value of $6,409,074.56.
Eric Andersen has bought the most Merrimack Pharmaceuticals Inc stock with a total value of $7,701,153.19.
The most recent insider trade for Merrimack Pharmaceuticals Inc was on Dec. 28, 2023.
The single biggest insider buy for Merrimack Pharmaceuticals Inc was from Eric Andersen with a total value of $1,849,996.80 on March 21, 2023.
The single biggest insider sell for Merrimack Pharmaceuticals Inc was from Robert J Mulroy with a total value of $1,968,000.00 on Dec. 8, 2014.